-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since a new type of monkeypox virus infection was detected in humans in May 2022, more than 52,000 cases have been confirmed in more than 90 countries and territories, and Hong Kong recorded its first imported case
In the past, VACV-based vaccines were mainly divided into three types
This year's outbreak of the MMXV-2022 virus carries different genetic variants that have the potential to affect vaccine-induced immune recognition
Professor MCKAY is also an Adjunct Professor at
Using genomic and immunological data, the team assessed genetic similarities and differences between VACV and MPXV-2022, particularly in the region
Professor McKay said: "While we have found small amounts of different mutations in MPXV-2022 with potential immunological effects, our study more broadly shows that VACV and MMXV-2022 are highly similar
Professor Quadeer said the findings were reassuring
The World Health Organization recommends a primary preventive vaccine against the neo-monkeypox virus for individuals at high risk of exposure, also known as pre-exposure prophylaxis